Literature DB >> 22113968

Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen.

Giacomo Venturi1, Alberto Gandini, Elena Monti, Luca Dalle Carbonare, Massimiliano Corradi, Monica Vincenzi, Maria Teresa Valenti, Maurizia Valli, Enrico Pelilli, Attilio Boner, Monica Mottes, Franco Antoniazzi.   

Abstract

Osteogenesis imperfecta (OI) is a clinically heterogeneous heritable connective tissue disorder, characterized by low bone mass and reduced strength, which result in susceptibility to fracture and bone deformities. In most cases it is caused by dominant mutations in type I collagen genes, COL1A1 and COL1A2. Recessive forms, which collectively account for approximately 5% of cases of osteogenesis imperfecta detected in North America and Europe, are caused instead by mutations in various genes coding for proteins involved in collagen posttranslational modifications, folding, and secretion. A novel disease locus, SERPINF1, coding for pigment epithelium-derived factor (PEDF), has been found recently. In SERPINF1 mutants described so far, synthesis, posttranslational modification, and secretion of type I collagen were reported to be normal. Here we describe three siblings born to consanguineous parents, who show an initially mild and then progressively worsening form of OI with severe deformities of the long bones. They are homozygous for a frameshift mutation in exon 4 of the SERPINF1 gene, which leads to lack of the transcription/translation product, likely a key factor in bone deposition and remodeling. Synthesis and secretion of type I collagen are normal. Clinical, radiographic, histological, and histomorphometric data from the proband are reminiscent of the distinctive features of type VI OI.
© 2012 American Society for Bone and Mineral Research

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22113968     DOI: 10.1002/jbmr.1480

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  24 in total

1.  Novel Deletion of SERPINF1 Causes Autosomal Recessive Osteogenesis Imperfecta Type VI in Two Brazilian Families.

Authors:  Renata Moldenhauer Minillo; Nara Sobreira; Maria de Fatima de Faria Soares; Julie Jurgens; Hua Ling; Kurt N Hetrick; Kimberly F Doheny; David Valle; Decio Brunoni; Ana B Alvarez Perez
Journal:  Mol Syndromol       Date:  2014-11-25

2.  The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutations.

Authors:  Kyu Sang Joeng; Yi-Chien Lee; Ming-Ming Jiang; Terry K Bertin; Yuqing Chen; Annie M Abraham; Hao Ding; Xiaohong Bi; Catherine G Ambrose; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2014-03-14       Impact factor: 6.150

Review 3.  Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation.

Authors:  Joan C Marini; Adi Reich; Simone M Smith
Journal:  Curr Opin Pediatr       Date:  2014-08       Impact factor: 2.856

4.  Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families.

Authors:  Osama Essawi; Sofie Symoens; Maha Fannana; Mohammad Darwish; Mohammad Farraj; Andy Willaert; Tamer Essawi; Bert Callewaert; Anne De Paepe; Fransiska Malfait; Paul J Coucke
Journal:  Mol Genet Genomic Med       Date:  2017-11-18       Impact factor: 2.183

5.  A mouse model for human osteogenesis imperfecta type VI.

Authors:  Rosalind Bogan; Ryan C Riddle; Zhu Li; Sarvesh Kumar; Anjali Nandal; Marie-Claude Faugere; Adele Boskey; Susan E Crawford; Thomas L Clemens
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

6.  Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content.

Authors:  Arijeet K Gattu; E Scott Swenson; Yasuko Iwakiri; Varman T Samuel; Nancy Troiano; Ryan Berry; Christopher D Church; Matthew S Rodeheffer; Thomas O Carpenter; Chuhan Chung
Journal:  FASEB J       Date:  2013-07-25       Impact factor: 5.191

7.  Contemporary Approaches for Identifying Rare Bone Disease Causing Genes.

Authors:  Charles R Farber; Thomas L Clemens
Journal:  Bone Res       Date:  2013       Impact factor: 13.567

Review 8.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

9.  Pigment epithelium derived factor regulates human Sost/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk/GSK-3beta/beta-catenin signaling.

Authors:  Feng Li; Jarret D Cain; Joyce Tombran-Tink; Christopher Niyibizi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-08-01       Impact factor: 5.187

10.  Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade.

Authors:  Glenn S Belinsky; Bharath Sreekumar; Jillian W Andrejecsk; W Mark Saltzman; Jingjing Gong; Raimund I Herzog; Samantha Lin; Valerie Horsley; Thomas O Carpenter; Chuhan Chung
Journal:  FASEB J       Date:  2016-04-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.